Family Medicine · Sacramento, CA
NPI
1184791048
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8191 Timberlake Way, Suite 400
Sacramento, CA, 95823
Phone (916) 688-8888
Groups this clinician bills Medicare through
Medicare paid, 2024
$600K
8,829 services
Medicare patients, 2024
839
Average age 73
Drug cost, 2024
$2.9M
38,089 prescriptions
Company payments, 2025
$1,303
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paramjit S Takhar was code 99214 (office e&m - established), 2,631 times for 729 patients. In total Paramjit S Takhar billed 8,829 services in 33 codes, and Medicare paid $600K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,631 | 729 | $95.32 | $251K |
| 99213 Office E&M - Established | Office | 2,604 | 678 | $65.65 | $171K |
| 99497 Care Management/Coordination | Office | 496 | 493 | $75.18 | $37K |
| 96372 Injection Administration | Office | 352 | 157 | $11.35 | $3,996 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 331 | 330 | $20.31 | $6,722 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 326 | 325 | $20.30 | $6,619 |
| G0008 Administration of influenza virus vaccine | Office | 284 | 262 | $34.15 | $9,699 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 274 | 142 | $0.91 | $251 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 234 | 234 | $136.59 | $32K |
| 92250 Angiography | Office | 229 | 221 | $27.36 | $6,265 |
| 90661 Vaccine Product | Office | 212 | 206 | $36.11 | $7,655 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 178 | 53 | $0.78 | $139 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 142 | 142 | $173.27 | $25K |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 123 | 123 | $173.48 | $21K |
| 99203 Office E&M - New | Office | 85 | 85 | $66.11 | $5,619 |
By year: 2022 $318K for 5,652 services; 2023 $336K for 5,751 services; 2024 $600K for 8,829 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 21 | 16 | $35.13 | $738 |
Medicare prescription drug claims, 2024
In 2024, the drug Paramjit S Takhar prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,625 prescriptions and refills. In total Paramjit S Takhar wrote 38,089 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,625 | 7,012 | 881 | $24K |
| Amlodipine Besylate Generic | 1,723 | 4,577 | 602 | $7,995 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 1,586 | 4,324 | 549 | $17K |
| Metformin Hcl Generic | 1,387 | 3,689 | 464 | $6,902 |
| Omeprazole Generic | 1,163 | 3,033 | 446 | $12K |
| Losartan Potassium Generic | 1,035 | 2,861 | 359 | $7,444 |
| Escitalopram Oxalate Generic | 1,022 | 2,635 | 389 | $12K |
| Glipizide Generic | 1,021 | 2,714 | 326 | $6,199 |
| Triamcinolone Acetonide Generic | 979 | 1,413 | 414 | $7,623 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 970 | 1,007 | 325 | $25K |
| Donepezil Hcl Generic | 970 | 2,593 | 354 | $8,552 |
| Levothyroxine Sodium Generic | 960 | 2,655 | 306 | $12K |
| Gabapentin Generic | 875 | 2,237 | 326 | $10K |
| Metoprolol Succinate Generic | 826 | 2,194 | 284 | $9,098 |
| Naproxen Generic | 678 | 690 | 265 | $2,967 |
Brand drugs: 4,084 claims; generic drugs: 33,427 claims; opioid claims: 112.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paramjit S Takhar $1,303 ($1,303 in general payments such as food, travel and fees) from 24 companies. The largest payer was GlaxoSmithKline, LLC. with $198.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 7 | $198 |
| Exact Sciences Corporation EXAS | 8 | $152 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $96.02 |
| Dexcom, Inc. DXCM | 3 | $90.39 |
| Pfizer Inc. PFE | 4 | $84.39 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $67.01 |
| Amgen Inc. AMGN | 4 | $63.69 |
| Novo Nordisk Inc NVO | 3 | $55.59 |
| Abbvie Inc. ABBV | 3 | $55.58 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $53.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.